US 11026974
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted A61KA61K2239/57A61K40/11
Quick answer
US patent 11026974 (Restimulation of cryopreserved tumor infiltrating lymphocytes) held by Iovance Biotherapeutics, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2239/57, A61K40/11, A61K40/4271, A61P